References
- Substance Abuse and Mental Health Services Administration. 2021. Buprenorphine. https://www.samhsa.gov/medication-assisted-treatment/treatment/buprenorphine.
- Hoffman KA, Ponce Terashima J, McCarty D. Opioid use disorder and treatment: challenges and opportunities. BMC Health Serv Res. 2019;19(1):884. doi:10.1186/s12913-019-4751-4.
- McCance-Katz EF. 2018. SAMHSA/HHS: an update on the opioid crisis. Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/sites/default/files/aatod_2018_final.pdf.
- McLellan AT. Technology transfer and the treatment of addiction: what can research offer practice? J Subst Abuse Treat. 2002;22(4):169–70. doi:10.1016/S0740-5472(02)00240-4.
- McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public’s demand for quality care? J Subst Abuse Treat. 2003;25(2):117–21.
- Clement S, Schauman O, Graham T, Maggioni F, Evans-Lacko S, Bezborodovs N, Morgan C, Rüsch N, Brown JS, Thornicroft G. What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychol Med. 2015;45(1):11–27. doi:10.1017/S0033291714000129.
- Wakeman SE, Rich JD. Barriers to medications for addiction treatment: how stigma kills. Subst Use Misuse. 2018;53(2):330–3. doi:10.1080/10826084.2017.1363238.
- World Health Organization. 2001. The World Health Report 2001: mental health: new understanding, new hope. https://www.google.com/books/edition/The_World_Health_Report_2001/GQEdA-VFSIgC?hl=en&gbpv=1&kptab=overview.
- Watson AC, Corrigan P, Larson JE, Sells M. Self-stigma in people with mental illness. Schizophr Bull. 2007;33(6):1312–8. doi:10.1093/schbul/sbl076.
- Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27(1):363–85. doi:10.1146/annurev.soc.27.1.363.
- Ashford RD, Brown AM, McDaniel J, Curtis B. Biased labels: an experimental study of language and stigma among individuals in recovery and health professionals. Subst Use Misuse. 2019;54(8):1376–84. doi:10.1080/10826084.2019.1581221.
- Kelly JF, Dow SJ, Westerhoff C. Does our choice of substance related terms influence perceptions of treatment need? An empirical investigation with two commonly used terms. J Drug Issues. 2010;40(4):805–18. http://journals.sagepub.com/ doi:10.1177/002204261004000403.
- Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202–7. doi:10.1016/j.drugpo.2009.10.010.
- Kameg BN. Shifting the paradigm for opioid use disorder: changing the language. J Nurse Pract. 2019;15(10):757–9. doi:10.1016/j.nurpra.2019.08.020.
- Allen B, Nolan ML, Paone D. Underutilization of medications to treat opioid use disorder: what role does stigma play? Subst Abus. 2019;40(4):459–65. doi:10.1080/08897077.2019.1640833.
- Langdon KJ, Ramsey S, Scherzer C, Carey K, Ranney ML, Rich J. Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder. Addict Sci Clin Pract. 2020;15(1):16. doi:10.1186/s13722-020-00189-4.
- Langdon KJ, Scherzer C, Ramsey S, Carey K, Rich J, Ranney ML. Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder. J Subst Abuse Treat. 2021;131:108538. doi:10.1016/j.jsat.2021.108538.
- Smith J, Firth J. Qualitative data analysis: the framework approach. Nurse Res. 2011;18(2):52–62. doi:10.7748/nr2011.01.18.2.52.c8284.
- QSR International. 1999. NVivo qualitative data analysis software. https://qsrinternational.com/nvivo/nvivo-products.
- Pivovarova E, Stein MD. In their own words: language preferences of individuals who use heroin. Addiction. 2019;114(10):1785–90. doi:10.1111/add.14699.
- McGinty EE, Stone EM, Kennedy-Hendricks A, Barry CL. Stigmatizing language in news media coverage of the opioid epidemic: implications for public health. Prev Med. 2019;124:110–4. doi:10.1016/j.ypmed.2019.03.018.
- Adams JM, Volkow ND. Ethical imperatives to overcome stigma against people with substance use disorders. AMA J Ethics. 2020;22(1):E702–708. doi:10.1001/amajethics.2020.702.
- National Institute on Drug Abuse. 2020. How effective are medications to treat opioid use disorder? Retrieved November 20 from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/efficacy-medications-opioid-use-disorder.
- Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007;11(9):1–171. doi:10.3310/hta11090.
- Hadland SE, Park TW, Bagley SM. Stigma associated with medication treatment for young adults with opioid use disorder: a case series. Addict Sci Clin Pract. 2018;13(1):15. doi:10.1186/s13722-018-0116-2.
- Yang LH, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatry. 2017;30(5):378–88. doi:10.1097/YCO.0000000000000351.
- Morse ED. Addiction is a chronic medical illness. N C Med J. 2018;79(3):163–5. doi:10.18043/ncm.79.3.163.
- Tracy K, Wallace SP. Benefits of peer support groups in the treatment of addiction. Subst Abuse Rehabil. 2016;7:143–54. doi:10.2147/SAR.S81535.
- Narcotics Anonymous. 2020. Narcotics Anonymous and Persons Receiving Medication-Assisted Treatment. Retrieved November from https://www.na.org/admin/include/spaw2/uploads/pdf/pr/2306NAPRMAT1021.pdf
- Batchelder AW, Foley JD, Wirtz MR, Mayer K, O’Cleirigh C. Substance use stigma, avoidance coping, and missed HIV appointments among MSM who use substances. AIDS Behav. 2021;25(5):1454–63. doi:10.1007/s10461-020-02982-3.
- National Academies of Sciences Engineering and Medicine. 2019. Barriers to broader use of medications to treat opioid use disorder. N. A. Press. Washington. https://www.ncbi.nlm.nih.gov/books/NBK541389/
- Goodyear K, Haass-Koffler CL, Chavanne D. Opioid use and stigma: the role of gender, language and precipitating events. Drug Alcohol Depend. 2018;185:339–46. doi:10.1016/j.drugalcdep.2017.12.037.
- Davis EL, Kelly PJ, Deane FP, Baker AL, Buckingham M, Degan T, Adams S. The relationship between patient-centered care and outcomes in specialist drug and alcohol treatment: a systematic literature review. Subst Abus. 2020;41(2):216–31. doi:10.1080/08897077.2019.1671940.
- Miles J, Howell J, Sheridan D, Braucht G, Mericle A. Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic. Am J Drug Alcohol Abuse. 2020;46(3):266–72. doi:10.1080/00952990.2020.1719410.
- Cooper LA, Roter DL, Carson KA, Beach MC, Sabin JA, Greenwald AG, Inui TS. The associations of clinicians’ implicit attitudes about race with medical visit communication and patient ratings of interpersonal care. Am J Public Health. 2012;102(5):979–87. doi:10.2105/AJPH.2011.300558.
- Benkert R, Peters RM, Clark R, Keves-Foster K. Effects of perceived racism, cultural mistrust and trust in providers on satisfaction with care. J Natl Med Assoc. 2006;98(9):1532–40.